morpholinoanthracycline MX2

Known as: 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin, MX-2, morpholinoanthracycline MX-2 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2016
0119882016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The environmental impact of the Three Gorges Reservoir (TGR) in China has raised widespread concern especially in relation to… (More)
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
Is this relevant?
2016
2016
BACKGROUND Sansanmycins are uridyl peptide antibiotics (UPAs), which are inhibitors of translocase I (MraY) and block the… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2004
2004
BACKGROUND/AIMS Mx proteins are supposed to be strictly regulated by viruses or interferon-alpha (IFN-alpha). We used a non-viral… (More)
Is this relevant?
Review
2002
Review
2002
With NASA’s resources dedicated to the six-fold increase in extravehicular operations required for the construction of… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2000
2000
The potential antitumor effect of MX2, a new lipophilic morpholino anthracycline, was compared with those of ACNU or doxorubicin… (More)
Is this relevant?
1993
1993
We performed a preliminary phase II clinical trial of MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in… (More)
Is this relevant?
1990
1990
An inhibition enzyme-linked immunosorbent assay (Inhibition ELISA) system for adriamycin has been established. In this assay… (More)
Is this relevant?
1989
1989
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and… (More)
  • table 1
  • figure 1
  • table 4
  • table 2
  • table 3
Is this relevant?
1988
1988
MX-2, a new morpholino anthracycline derivative, showed broad anti-neoplastic activity against experimental tumors. Molecular… (More)
Is this relevant?